The cardiac safety services market encompasses a range of services and technologies aimed at ensuring the cardiovascular safety of new drugs and medical treatments. These services are essential during clinical trials and post-marketing phases to detect potential cardiac risks, such as arrhythmias or QT prolongation, which can lead to serious health complications. Cardiac safety services include electrocardiogram (ECG) analysis, cardiac imaging, blood pressure monitoring, and more, ensuring the cardiovascular safety of patients throughout the drug development process.